Skip to content

The effect of lidocaine spray on the pleura on the incidence of perioperative atrial fibrillation in thoracoscopic lobectomy/segmentectomy: A single-center, prospective, open-label clinical study

The effect of lidocaine spray on the pleura on the incidence of perioperative atrial fibrillation in thoracoscopic lobectomy/segmentectomy: A single-center, prospective, open-label clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104353
Enrollment
Unknown
Registered
2025-06-16
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative atrial fibrillation

Interventions

Normal saline group:Spray 10 ml of normal saline onto the surface of the visceral pleura
Lidocaine group:Spray 10 ml of 2% lidocaine onto the surface of the dirty pleura

Sponsors

Fujian Medical University Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Participants undergoing thoracoscopic lobectomy/segmentectomy under elective general anesthesia; 2. The participants' ages range from 45 to 75 years old; 3. ASA Grade II - III; 4. Be able to comply with the requirements of the research visit plan and other programs; 5. Sign the informed consent form and voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: 1. Participants with a previous history of atrial fibrillation; 2. Participants who are currently taking antiarrhythmic drugs such as beta-blockers, calcium channel blockers or digoxin; 3. Participants with contraindications to lidocaine use (For example: lidocaine allergy); 4. Participants with severe systemic diseases; 5. Participants who refused to participate in this trial; 6. Participants with severe liver and kidney dysfunction; 7. Participants with severe cardiovascular diseases.

Design outcomes

Primary

MeasureTime frame
The incidence of atrial fibrillation during the perioperative period of thoracic surgery;

Secondary

MeasureTime frame
Intraoperative hemodynamic analysis;The consumption of vasoactive drugs during the operation;The incidence of atrial fibrillation within 3 days after the operation;The length of hospital stay of the patient;Postoperative VAS score;PCIA consumption and cumulative number of compressions;Incidence of other adverse reactions;C-reactive protein;Interleukin-6;Neutrophil-to-lymphocyte ratio;N-terminal pro-brain natriuretic peptide;Cardiac troponin I;Electrolyte levels: serum magnesium; serum potassium; serum sodium;

Countries

China

Contacts

Public ContactZhongmeng Lai

Fujian Medical University Union Hospital

angerer1980@163.com+86 133 9500 0771

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026